Robert Michiels
Director/Board Member at Embolization Prevention Technologies
Profile
Robert Michiels is currently the Director at Embolization Prevention Technologies.
He is also an Independent Director at FEops NV, Director at Atrius Ltd., Director at Aegis Surgical Ltd., Founding Partner at Consilium Associates LLC, and Senior Venture Partner at 415 Capital Management GmbH.
In his former positions, Mr. Michiels served as the Chief Executive Officer & Director at Edwards Lifesciences CardiaQ LLC from 2011 to 2015.
He was also the Chief Executive Officer & Director at VenPro Corp., President, Chief Operating Officer & Director at Medtronic CoreValve LLC, President, Chief Operating Officer & Director at Interventional Technologies, Inc. from 1991 to 1998, Independent Director at EDAP TMS SA, and Chief Operating Officer at CoreValve SA from 2004 to 2009.
Mr. Michiels holds an MBA from Indiana University and an undergraduate degree from the University of Antwerp.
Robert Michiels active positions
| Companies | Position | Start |
|---|---|---|
| Embolization Prevention Technologies | Director/Board Member | - |
| Consilium Associates LLC | Corporate Officer/Principal | 1999-12-31 |
Aegis Surgical Ltd.
 Aegis Surgical Ltd. Medical SpecialtiesHealth Technology Aegis Surgical Ltd. develops healthcare equipment for the treatment of symptomatic aortic stenosis. The company was founded by William N. Starling Jr. and is headquartered in Dublin, Ireland. | Director/Board Member | - |
Atrius Ltd.
 Atrius Ltd. Medical/Nursing ServicesHealth Services Atrius Ltd. operates a healthcare center. The company is based in Ledbury, UK. The British company was founded in 2003 by William N. Starling, who has been the CEO since 2003. | Director/Board Member | - |
FEops NV
 FEops NV Medical SpecialtiesHealth Technology FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium. | Independent Dir/Board Member | 2023-01-11 |
415 Capital Management GmbH
 415 Capital Management GmbH Investment ManagersFinance 415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany. | Private Equity Investor | - |
Former positions of Robert Michiels
| Companies | Position | End |
|---|---|---|
Edwards Lifesciences CardiaQ LLC
 Edwards Lifesciences CardiaQ LLC Medical SpecialtiesHealth Technology Edwards Lifesciences CardiaQ LLC operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement. The firm focuses on mitral regurgitation which is the most commonly occurring heart valve disease. The company was founded by Arshad Quadri and J. B. Ratz in 2007 and is headquartered in Irvine, CA. | Chief Executive Officer | 2014-12-31 |
CoreValve SA
 CoreValve SA Medical SpecialtiesHealth Technology CoreValve SA develops implants and instruments for heart surgery. It offers aortic bioprostheses, delivery catheters, disposable loading systems and other related products. The company was founded by Jacques Seguin in 2001 and is headquartered in Paris, France. | Chief Operating Officer | 2008-12-31 |
Interventional Technologies, Inc.
 Interventional Technologies, Inc. Medical SpecialtiesHealth Technology Interventional Technologies' products are helping to combat this. The company's major contributions have been in the field of microprecision fabrication techniques as applied to cardiovascular products. Some of these include: guide catheters, guide wires, microsurgical dilatation catheters, site-specific drug delivery catheters (injecting drugs, gene therapy or radio-pharmaceuticals directly into the coronary artery wall) and a photo-mask-and-etch-on-a-tube chemical milling manufacturing process for cardiovascular stents | President | 1997-12-31 |
| ░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of Robert Michiels
| Indiana University | Masters Business Admin |
| University of Antwerp | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EDAP TMS S.A. | Health Technology |
| Private companies | 11 |
|---|---|
Medtronic CoreValve LLC
 Medtronic CoreValve LLC Medical SpecialtiesHealth Technology Medtronic CoreValve LLC develops transcatheter technologies for failing aortic heart valves. Its proprietary ReValving System allows both percutaneous (PAVR) and transapical aortic valve replacement (TAVR) and is intended to provide an alternative to open-heart surgery. The company was founded by Jacques Seguin in 2001 and is located in Irvine, CA. | Health Technology |
Edwards Lifesciences CardiaQ LLC
Edwards Lifesciences CardiaQ LLC Medical SpecialtiesHealth Technology Edwards Lifesciences CardiaQ LLC operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement. The firm focuses on mitral regurgitation which is the most commonly occurring heart valve disease. The company was founded by Arshad Quadri and J. B. Ratz in 2007 and is headquartered in Irvine, CA. | Health Technology |
Interventional Technologies, Inc.
Interventional Technologies, Inc. Medical SpecialtiesHealth Technology Interventional Technologies' products are helping to combat this. The company's major contributions have been in the field of microprecision fabrication techniques as applied to cardiovascular products. Some of these include: guide catheters, guide wires, microsurgical dilatation catheters, site-specific drug delivery catheters (injecting drugs, gene therapy or radio-pharmaceuticals directly into the coronary artery wall) and a photo-mask-and-etch-on-a-tube chemical milling manufacturing process for cardiovascular stents | Health Technology |
VenPro Corp.
 VenPro Corp. Medical SpecialtiesHealth Technology VenPro Corp. was an early stage company focused on the development of bioprosthetic implants for the treatment of venous diseases. The company was headquarted in Irvine, CA. | Health Technology |
CoreValve SA
CoreValve SA Medical SpecialtiesHealth Technology CoreValve SA develops implants and instruments for heart surgery. It offers aortic bioprostheses, delivery catheters, disposable loading systems and other related products. The company was founded by Jacques Seguin in 2001 and is headquartered in Paris, France. | Health Technology |
| Embolization Prevention Technologies | |
| Consilium Associates LLC | |
FEops NV
FEops NV Medical SpecialtiesHealth Technology FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium. | Health Technology |
Atrius Ltd.
Atrius Ltd. Medical/Nursing ServicesHealth Services Atrius Ltd. operates a healthcare center. The company is based in Ledbury, UK. The British company was founded in 2003 by William N. Starling, who has been the CEO since 2003. | Health Services |
Aegis Surgical Ltd.
Aegis Surgical Ltd. Medical SpecialtiesHealth Technology Aegis Surgical Ltd. develops healthcare equipment for the treatment of symptomatic aortic stenosis. The company was founded by William N. Starling Jr. and is headquartered in Dublin, Ireland. | Health Technology |
415 Capital Management GmbH
415 Capital Management GmbH Investment ManagersFinance 415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany. | Finance |
- Stock Market
- Insiders
- Robert Michiels
